These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26619926)

  • 1. [Anti-pneumococcal vaccine coverage for hospitalized risk patients: Assessment and suggestions for improvements].
    Richard C; Le Garlantezec P; Lamand V; Rasamijao V; Rapp C
    Ann Pharm Fr; 2016 May; 74(3):244-51. PubMed ID: 26619926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention?
    Arencibia Jiménez M; Navarro Gracia JF; Delgado de Los Reyes JA; Pérez Torregrosa G; López Parra D; López García P
    Arch Bronconeumol; 2014 Mar; 50(3):93-8. PubMed ID: 24315186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.
    Yang TU; Kim E; Park YJ; Kim D; Kwon YH; Shin JK; Park O
    Vaccine; 2016 Mar; 34(13):1623-1629. PubMed ID: 26850759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Improvement of pneumococcal immunization coverage in older patients].
    Krypciak S; Liuu E; Vincenot M; Landelle C; Lesprit P; Cariot MA; Mézière A; Taillandier-Hériche E; Leroux JL; Canoui-Poitrine F; Paillaud E
    Rev Med Interne; 2015 Apr; 36(4):243-7. PubMed ID: 24973294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influenzae and pneumococcal vaccination rate in an internal medicine ward].
    Goulenok T; Chopin D; De Lastours V; Zarrouk V; Lepeule R; Fantin B; Lefort A
    Rev Med Interne; 2018 Jun; 39(6):386-392. PubMed ID: 29571580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carriage of Streptoccoccus pneumoniae 7 years after implementation of vaccination program in a population with very high and long-lasting coverage, Italy.
    Ansaldi F; de Florentiis D; Canepa P; Zancolli M; Martini M; Orsi A; Durando P; Icardi G
    Vaccine; 2012 Mar; 30(13):2288-94. PubMed ID: 22306795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014.
    Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB;
    MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists as providers: targeting pneumococcal vaccinations to high risk populations.
    Taitel M; Cohen E; Duncan I; Pegus C
    Vaccine; 2011 Oct; 29(45):8073-6. PubMed ID: 21864625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method for ascertaining denominators for evaluation of population coverage with pneumococcal vaccine.
    Schopflocher DP; Russell ML
    Can J Public Health; 2003; 94(5):377-80. PubMed ID: 14577749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight years of active proposal of pneumococcal 23-valent polysaccharide vaccine: survey on coverage rate among elderly and chronic patients.
    Martinelli D; Tafuri S; Caputi G; Fortunato F; Reggio P; Germinario C; Prato R
    Am J Infect Control; 2010 May; 38(4):e8-e15. PubMed ID: 20211508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza and pneumococcal vaccine coverages in geriatric health care settings in france.
    Gavazzi G; Wazieres B; Lejeune B; Rothan-Tondeur M
    Gerontology; 2007; 53(6):382-7. PubMed ID: 17622768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New opportunity for vaccinating older people: well-child clinic visits.
    Arslan I; Beyazova U; Aksakal N; Polat S; Camurdan AD; Sahin F
    Pediatr Int; 2012 Feb; 54(1):45-51. PubMed ID: 21917062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort.
    Hmamouchi I; Winthrop K; Launay O; Dougados M
    Vaccine; 2015 Mar; 33(12):1446-52. PubMed ID: 25659279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving pneumococcal vaccination coverage among older people in Victoria.
    Andrews RM; Lester RA
    Med J Aust; 2000 Oct; 173(S2):S45-7. PubMed ID: 11062807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.